China online Medical B2B, Global trade platform!
企业入驻 My member Message Center
International
  • English
  • العربية
  • Русский
  • Español
  • Français
  • India
Products
sign in
join free
Join Free
JIANGSU BIODA LIFE SCIENCE CO., LTD.
verified Ordinary Member

JIANGSU BIODA LIFE SCIENCE CO., LTD.

Jiangsu,China

home product company profile Certifications Exhibition contact

JIANGSU BIODA LIFE SCIENCE CO., LTD.

Jiangsu,China

favorite supplier

verified Ordinary Member
home product company profile Certifications contact
JIANGSU BIODA LIFE SCIENCE CO., LTD.
favorite supplier
verified Ordinary Member

JIANGSU BIODA LIFE SCIENCE CO., LTD.

Jiangsu,China

Scan QR code

Access to mobile station

home product company profile Certifications contact

company profile

company profile

Business Type :Manufacturer

Country/Region : Jiangsu,China

Main Products : Disposable medical consumables, Operating Consumables, Medical Textile

Annual Revenue :

Address :/

Main Markets :

company profile

JIANGSU BIODA LIFE SCIENCE Co., LTD. was established in 2015, and currently has two production and R&D bases in Shanghai and Nantong. At the beginning of 2022, BIODA Life science Park in Nantong North High-tech City, covering an area of 25,000 square meters, started construction. The first phase of the 15,000-square-meter vascular graft production plant was put into operation in December 2022. The company has set up an R&D center in Shanghai Zhangjiang Medical Valley, which has been stationed in October 2022. R&D center laboratory covers an area of 6,500 square meters, which can meet the development and production of a variety of products.

Since its establishment, BIODA and its subsidiaries have won the innovation fund support of Shanghai “Science and technology Innovation Action Plan” and the Outstanding Enterprise Award of “Enterpreneurship in Shanghai” International Innovation and Entrepreneurship Competition for many times. It was awarded into the “high-tech Enterprise Cultivation Pool” of Jiangsu Province, and won the title of “National high-tech Enterprise”.

VASOLINE® vascular graft was approved by NMPA on November 6, 2022 (NMPA 20223131515); Dialysis vascular prosthesis is currently in the clinical trial stage, and the product has been praised by doctors for its high quality.

At present, the company has more than 20 research projects, covering cardiovascular surgery,  vascular surgery, cardiac surgery, general surgery and other departments. Relying on the technology platform of polymer materials, biological materials and metal scaffold molding, BIODA is constantly introducing more high-quality products for clinical needs to benefit of patients.
More

email to this supplier

  • TO :
  • from : *
  • message : *
Send
Sign In Join Free